Furthermore, our group and Gonzales et al. showed that treatment with NaPB improved biochemical parameters and liver histology in PFIC2 patients with mutations in ABCB11 that severely affect the hepatocanalicular expression of BSEP but not its transport activity14,16–19. The gene discussed is ABCB11; the disease is progressive familial intrahepatic cholestasis type 2.